View in EDS HTML Full Text PDF Full Text

SEPT9 methylation as a diagnostic and predictive biomarker in the progression of ductal carcinoma in situ to invasive breast cancer.

Saved in:
Bibliographic Details
Title: SEPT9 methylation as a diagnostic and predictive biomarker in the progression of ductal carcinoma in situ to invasive breast cancer.
Authors: Guo, Yuan1 (AUTHOR), Zhou, Xiaoli1 (AUTHOR), Xu, Haoran1 (AUTHOR), Wang, Gengfang1 (AUTHOR) wanggengfang1986@163.com
Source: Scientific Reports. 11/21/2025, Vol. 15 Issue 1, p1-8. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20452322
DOI:10.1038/s41598-025-25096-z